Edesa Biotech is trading 5.49% lower at $3.79, with no company-specific announcement identified for September 28.
- The company’s news page lists its latest announcement on September 23, about a public offering.
- Broader market weakness comes as investors weigh rising oil prices, Treasury yields, and geopolitical tensions.
- Available information does not confirm a direct link between those pressures and the stock’s decline.